HIV:
A Normal Life with Treatment — Adherence, PrEP & U=U

At a glance

How commonAccording to an RKI estimate, around 97,700 people were living with HIV in Germany at the end of 2024, about 8,200 of them undiagnosed
DefinitionChronic infection with the human immunodeficiency virus; if untreated, it weakens the immune system and can lead to AIDS
Treatment of choiceAntiretroviral combination therapy (ART) from diagnosis, usually one tablet a day or injections every two months
U=UIf the virus remains undetectable on treatment, HIV is not transmitted sexually
GuidelineGerman-Austrian guidelines on antiretroviral therapy (DAIG, AWMF 055-001, 2025)
ICD-10B20–B24 (HIV disease) · Z21 (asymptomatic HIV infection)

HIV treatment: every dose, every interaction in view

Daily doses, injection appointments and other medications in one place — free in the brite app.

Create a treatment plan

1. What is HIV?

HIV stands for human immunodeficiency virus. It mainly infects CD4 helper cells, an important group of immune cells, and multiplies inside them. If left untreated, their number falls over the years until the immune system can no longer fight off pathogens adequately. This late stage is called AIDS (acquired immunodeficiency syndrome).¹

The most important message first: with treatment started in good time, people with HIV today have a near-normal life expectancy. The infection cannot yet be cured, because the virus permanently stores its genetic material in resting immune cells. However, the medications suppress its replication so reliably that it can no longer be detected in the blood.¹,²

According to an estimate by the Robert Koch Institute (RKI, Germany's public health institute), around 97,700 people were living with HIV in Germany at the end of 2024; about 2,300 new infections occurred in 2024. Almost everyone with a known diagnosis is being treated, and treatment works for the vast majority. The problem lies with the roughly 8,200 infections that people are unaware of — and with late diagnoses: around a third of the infections newly identified in 2024 were only detected once the immune deficiency was already advanced.³

HIV, hepatitis, herpes — three different viruses. HIV is partly transmitted in the same ways as hepatitis B and C, but it follows a completely different course and is treated with different medications. Herpes is also a separate infection. Because the routes of transmission overlap, people diagnosed with HIV are usually also tested for hepatitis and other sexually transmitted infections.

2. Course: from infection to AIDS

Without treatment, HIV infection typically progresses in three phases.¹

PhaseTimeframeWhat happens
Acute infectionA few days to a few weeks after infectionThe virus multiplies rapidly; the risk of transmission is particularly high in this phase. Often flu-like symptoms, sometimes none at all
Phase with few symptomsOften many yearsFew or no symptoms, but the number of helper cells declines gradually
AIDSIf untreated, after about ten years on average, varying widelySevere “opportunistic” infections and certain cancers that hardly ever occur when the immune system is intact
Table scrolls to the right

Doctors also classify the course according to symptoms and the number of helper cells. If this falls below about 200 per microlitre of blood, the risk of AIDS-defining illnesses rises sharply. With treatment, the immune system usually recovers — the earlier treatment starts, the better.²


3. Symptoms and warning signs

Acute HIV infection

Some people notice symptoms a few days to weeks after infection that are easily mistaken for flu or glandular fever:¹

  • Fever, exhaustion and aching limbs
  • Swollen lymph nodes and a sore throat
  • A rash on the upper body, often blotchy and not itchy
  • Painful sores in the mouth, diarrhoea or headaches

The symptoms disappear on their own after one to two weeks — the infection remains. If you have such symptoms after a risk contact, ask specifically about an HIV test.

Signs of advanced infection

Certain illnesses are considered indicator conditions for which an HIV test should be offered: shingles at a younger age, recurrent pneumonia, oral thrush, hepatitis B or C, syphilis or persistent changes in the blood count. Unintentional weight loss, night sweats and long bouts of diarrhoea can also be signs.²

When you need medical help immediately. With known, untreated or advanced HIV infection, increasing shortness of breath with a dry cough and fever, severe headache with a stiff neck, confusion, seizures or sudden paralysis are an emergency — they may be caused by serious infections. Go to the emergency department straight away or call 112 (emergency number in Germany).

4. Transmission and risks

HIV is transmitted through blood, semen, vaginal fluid, the fluid on the lining of the rectum and breast milk — provided the viral load is high enough and the virus reaches mucous membranes or the bloodstream.¹

  • Unprotected anal or vaginal sex with a person who has HIV and is not effectively treated — the most common route.
  • Sharing needles, syringes and equipment when using drugs.
  • From mother to child during pregnancy, birth or breastfeeding — very rare today with treatment.
  • Increased risk with other sexually transmitted infections that damage the mucous membranes, such as syphilis or herpes.

Everyday contact carries no risk: shaking hands, hugging, kissing, sharing crockery, toilets, swimming pools, coughing or insect bites do not transmit HIV.

Medications, drugs and risk. HIV is not caused by medications — but substances do influence the risk. Under the influence of alcohol, cannabis or party drugs (chemsex), people use protection less often, and shared equipment transmits viruses. Conversely, medications protect very effectively: the treatment itself (U=U), PrEP, and PEP after a risk contact (section 8). More on substances and medicines in the guide Medications and cannabis.

5. HIV testing and diagnosis

Only a test can give you certainty. It is important to have it at the right time — after infection, the immune system needs a few weeks before the test shows a result:¹

  • Laboratory test (combination test): detects antibodies and a component of the virus. A negative result reliably rules out infection six weeks after the risk.
  • Rapid test and self-test: give a result within minutes; reliable from twelve weeks after the risk. Self-tests are available from pharmacies, chemists and online — look for the CE mark.
  • Confirmatory test: a positive screening result is always confirmed in the laboratory before the diagnosis is made.
  • Anonymous and free of charge: many local public health offices and the checkpoints run by AIDS service organisations (Aidshilfe) offer testing and counselling.
  • After diagnosis: viral load, helper cell count, a resistance test of the virus, kidney and liver values, and tests for hepatitis and other infections form the basis for choosing treatment.²

Laboratories report positive HIV results to the RKI without names — your name is not passed on. What the individual laboratory values mean is explained in the guide Understanding blood values.

6. HIV treatment today

The guideline recommends starting antiretroviral therapy (ART) in every person with HIV — as soon as possible after diagnosis, regardless of the helper cell count. The aim is a viral load below the limit of detection. This protects the immune system, lowers the risk of secondary illnesses and prevents transmission.²

Treatment always uses a combination of active substances from different classes, so that the virus does not develop resistance. Many combinations are now available as one tablet once a day.

First line Integrase inhibitor-based combinations
Bictegravir/emtricitabine/tenofovir alafenamide
Three active substances in one tablet, once a day, with or without food. High barrier to resistance and comparatively few interactions.
Dolutegravir plus two other active substances
For example with emtricitabine/tenofovir or as a combination tablet with abacavir/lamivudine; before abacavir is started, a genetic test (HLA-B*5701) is carried out to check for hypersensitivity.
Dolutegravir/lamivudine
Dual combination in one tablet; suitable if there is no hepatitis B and no resistance.
Alternatives Injection instead of tablets, or boosted therapy
Cabotegravir plus rilpivirine as a long-acting injection
Two injections into the buttock muscle, given at the practice monthly or every two months depending on the schedule. For adults whose virus is already stably suppressed on tablets and shows no resistance to these active substances. The appointments must be kept reliably.
Darunavir with a booster (cobicistat or ritonavir)
Protease inhibitor with a very high barrier to resistance, for example in cases of resistance or uncertainty about taking it regularly. The booster inhibits the breakdown of many other medications — hence a particularly large number of interactions.

The medications are now usually well tolerated. At the start, nausea, headaches, sleep problems or diarrhoea can occur, and these often ease after a few weeks. Weight gain has been described with some combinations, especially those containing integrase inhibitors and tenofovir alafenamide. The HIV specialist practice decides which combination is right based on the resistance test, other conditions, other medications and your daily life.²,⁴


7. Adherence and interactions

Why every dose counts

HIV treatment only works if drug levels in the blood remain high enough at all times. If doses are repeatedly missed, the virus can multiply and develop resistance — then not only the current medications work less well, but often related active substances too.² How long you can still take a missed tablet varies by product and is stated in the package leaflet; if in doubt, ask your practice or pharmacy. General tips in the guide Missed a medication.

Never stop or pause HIV medications on your own. Even after a short break, the viral load rises again, the virus can be transmitted and can develop resistance. If you also have hepatitis B, stopping tenofovir, emtricitabine or lamivudine can additionally trigger a severe flare-up of liver inflammation. Side effects, supply shortages or a wish to change treatment should be raised with your practice — treatment can be switched there if needed. More in the guide Stopping medications.

The most important interactions

HIV medications are broken down by the same liver enzymes as many other medicines. According to the product information, the following groups are particularly important:⁴

RemedyProblemWhat usually happens
Magnesium, calcium, iron, zinc, antacidsBind integrase inhibitors in the gut and reduce their absorptionTime gap or taking them together with a meal — rules depend on the product
Acid blockers such as omeprazoleGreatly reduce the absorption of rilpivirine tabletsDo not combine with rilpivirine tablets
St John's wort, rifampicin, carbamazepineSpeed up the breakdown of many HIV drugs — risk of treatment failureUsually cannot be combined
MetforminDolutegravir and bictegravir increase metformin levelsMonitoring, dose adjustment by the practice if needed
With a booster: simvastatin, certain sleeping tablets, rivaroxabanLevels rise sharply — muscle damage, oversedation or bleeding possibleSome are contraindicated; otherwise an alternative or dose adjustment
With a booster: cortisone sprays such as fluticasoneCortisone is barely broken down; Cushing's syndrome and adrenal insufficiency possibleSwitch to other products
With a booster: erectile dysfunction medicines such as sildenafil, and party drugsMuch higher levels; drop in blood pressure and poisoning possibleOnly after consultation, at a reduced dose
Table scrolls to the right

Over-the-counter medicines, dietary supplements and herbal products are the ones most often overlooked. Show your complete medication list to every practice and pharmacy before anything new is added — background in the guide Understanding drug interactions.

One tablet a day — for life, without gaps?

brite reminds you of every dose and every injection appointment and checks new remedies for interactions.

Set up a reminder

8. U=U, PrEP and PEP

U=U: undetectable means untransmittable

Large studies of couples in which only one partner had HIV have shown: if the viral load on treatment has been below the limit of detection for at least six months and treatment continues to be taken reliably, HIV is not transmitted during sex — even without a condom.¹,² This message, known in German as “n=n”, is one of the greatest advances against stigma. However, U=U does not protect against other sexually transmitted infections.

PrEP: protection against infection

Pre-exposure prophylaxis is a preventive treatment for HIV-negative people at increased risk. The standard is a tablet containing tenofovir disoproxil and emtricitabine, taken daily or — for men who have sex with men — also on demand according to a fixed schedule, as set out in the guideline. Taken correctly, it protects very reliably.⁵

  • Cost coverage: people with statutory health insurance aged 16 and over with a substantial HIV risk receive PrEP, including counselling and check-ups, at the insurance fund's expense.
  • Check-ups: before starting and then regularly, usually every three months, tests for HIV, other sexually transmitted infections and kidney function.
  • Long-acting injections: long-acting injections for PrEP are also approved in the EU — cabotegravir every two months and, since 2025, lenacapavir twice a year.⁶ Whether and under what conditions they are offered and reimbursed in Germany can be clarified by your PrEP practice.

PEP: emergency treatment after a risk

After a risk contact, such as a split condom with a partner whose HIV status is unknown or untreated, post-exposure prophylaxis can prevent infection. It must start as quickly as possible — ideally within a few hours, at the latest after 48 to 72 hours — and is taken for four weeks.⁷ Places to go are HIV specialist practices, hospitals with an infectious diseases outpatient clinic and, at night or at weekends, the emergency department.


9. Pregnancy, vaccinations and getting older

Wanting children and pregnancy

People with HIV can have children without infecting their partner or child. With effective treatment and an undetectable viral load, the risk of transmission to the child is very low; a vaginal birth is then usually possible, and the newborn receives preventive medication for a short time. Pregnant women are offered an HIV test as part of antenatal care. Whether breastfeeding is an option is now discussed individually with the practice if the viral load is permanently suppressed.⁸ Which active substances are suitable during pregnancy is decided by the specialist practice — see also Medications during pregnancy.

Vaccinations

STIKO (Germany's Standing Committee on Vaccination) recommends that people with HIV receive vaccinations against pneumococci, flu and hepatitis B, among others, against hepatitis A and HPV if needed, and against shingles from as early as age 50. Live vaccines, such as those against measles or chickenpox, are only an option if the helper cell count is high enough.⁹ The guide Vaccinations for adults gives an overview.

Getting older with HIV

Because treatment works so well, people with HIV now grow old — and develop the typical conditions of older age, sometimes somewhat earlier: cardiovascular disease, kidney impairment, osteoporosis, diabetes. Screening and checks of blood pressure and cholesterol therefore become more important, as does keeping an eye on interactions when taking many medications.²


10. Living with HIV

  • A fixed time for your dose — link it to a daily routine, such as brushing your teeth, and carry a small supply with you when you are out.
  • Keep your check-up appointments — viral load and laboratory values are usually checked every three to six months, and on a fixed schedule with long-acting injections.
  • Plan your travel — keep medications in your hand luggage and adjust the time you take them gradually when crossing time zones; tips in the guide Medications when travelling.
  • Work and sport — HIV is no obstacle to the vast majority of jobs and sports. As a rule, you do not have to tell your employer.
  • Mental health — the shock of diagnosis, stigma and worries about relationships take their toll. Counselling at AIDS service organisations and psychotherapy can help; if low mood persists, see depression.

All medications belong in an up-to-date plan — including those you buy for self-medication. The guide Creating a medication plan helps you put one together.

Viral load, helper cells, appointments — what happened when?

Record laboratory values and check-up appointments over time and bring them neatly organised to your next appointment.

Start tracking

FAQ: Common questions about HIV

No, not yet. The virus permanently stores its genetic material in resting immune cells. However, antiretroviral therapy suppresses its replication so reliably that the virus can no longer be detected in the blood. With timely treatment, people with HIV today have a near-normal life expectancy.
U=U stands for “undetectable equals untransmittable”. If the viral load on treatment has been below the limit of detection for at least six months and treatment continues to be taken reliably, HIV is not transmitted during sex. It does not protect against other sexually transmitted infections.
A laboratory test (combination test) reliably rules out infection six weeks after the risk contact. Rapid tests and self-tests are only reliable twelve weeks after the risk. A positive result is always checked with a confirmatory test in the laboratory.
A single missed dose can be taken later within a certain time window, depending on the product; the rule is stated in the package leaflet. If doses are missed repeatedly, however, the virus can multiply and develop resistance. The medications then work less well, and treatment has to be changed.
PrEP is intended for HIV-negative people at increased risk of infection. People with statutory health insurance aged 16 and over with a substantial risk receive the tablets, counselling and regular check-up tests at the insurance fund's expense. It is prescribed by practices qualified to do so.
Yes. The combination of cabotegravir and rilpivirine is injected at the practice monthly or every two months, depending on the schedule. It is an option for adults whose virus is already stably suppressed on tablets and shows no resistance to these active substances. The injection appointments must be kept reliably.
Important examples are St John's wort, certain anti-epileptic drugs and tuberculosis medicines, magnesium, calcium and iron preparations without a time gap, acid blockers together with rilpivirine and, with boosted treatments, certain cholesterol-lowering drugs, cortisone sprays and erectile dysfunction medicines. Which combination is problematic depends on the product. That is why every new remedy should be checked with your practice or pharmacy beforehand.

Sources

  1. Robert Koch Institute: RKI guide to HIV infection/AIDS. Accessed 2026 — German source. rki.de
  2. German-Austrian guidelines on antiretroviral therapy of HIV-1 infection, German AIDS Society (DAIG) and Austrian AIDS Society (AWMF reg. no. 055-001, version 2025) — German source. daignet.de
  3. Robert Koch Institute: HIV/AIDS in Germany — key data of the estimate, Epidemiological Bulletin 47/2025 — German source. rki.de
  4. European Medicines Agency (EMA): product information for Biktarvy, Tivicay, Dovato, Triumeq, Edurant, Vocabria/Rekambys and Rezolsta. Accessed 2026. ema.europa.eu
  5. German-Austrian guidelines on HIV pre-exposure prophylaxis, German AIDS Society (DAIG) (AWMF reg. no. 055-008, version 2024) — German source. awmf.org
  6. European Medicines Agency (EMA): product information for Apretude (cabotegravir) and Yeytuo (lenacapavir) for HIV pre-exposure prophylaxis. Accessed 2026. ema.europa.eu
  7. German-Austrian guideline on post-exposure prophylaxis (PEP) with medication after HIV exposure, German AIDS Society (DAIG) (AWMF reg. no. 055-004, 2022) — German source. awmf.org
  8. German-Austrian guideline on HIV therapy in pregnancy and in HIV-exposed newborns, German AIDS Society (DAIG) (AWMF reg. no. 055-002, 2020) — German source. awmf.org
  9. Standing Committee on Vaccination (STIKO): STIKO recommendations at the Robert Koch Institute, Epidemiological Bulletin, current version. Accessed 2026 — German source. rki.de/stiko

HIV treatment you can rely on every day — with brite

Every dose reminded, every interaction checked, every lab value documented. Free of charge.

Start now
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. After an HIV risk contact, every hour counts — contact a specialist practice or an emergency department immediately for PEP. Never stop HIV medications on your own and do not take any new remedies without checking first. The choice of medicine and its dose are always set individually by the treating practice. Last updated: October 2026.